Company Krebs Biochemicals & Industries Limited NSE India S.E.
Equities
KREBSBIO
INE268B01013
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.95 INR | -0.49% |
|
-0.52% | -9.44% |
Business Summary
Number of employees: 210
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredients
100.0
%
| 529 | 100.0 % | 521 | 100.0 % | -1.52% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 529 | 100.0 % | 521 | 100.0 % | -1.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jitendra Shah
CEO | Chief Executive Officer | - | 08/11/21 |
Founder | 74 | 01/12/91 | |
Ritesh Jain
DFI | Director of Finance/CFO | - | 02/02/23 |
Director/Board Member | 55 | - | |
Avinash Ravi
BRD | Director/Board Member | 45 | 31/12/01 |
Sudhir Manne
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 25/09/00 | |
Founder | 74 | 01/12/91 | |
Avinash Ravi
BRD | Director/Board Member | 45 | 31/12/01 |
Director/Board Member | 75 | 11/02/16 | |
Malati Tangirala
BRD | Director/Board Member | 74 | 31/12/13 |
Director/Board Member | 79 | 28/09/15 | |
Director/Board Member | 55 | - | |
Jitendra Shah
CEO | Chief Executive Officer | - | 08/11/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,560,600 | 4,839,509 ( 22.45 %) | 0 | 22.45 % |
Company contact information
Krebs Biochemicals & Industries Ltd.
Plot No.34, 8-2-577/B 3rd Floor, Maas Heights
500034, Hyderabad
+
http://krebsbiochem.com![address Krebs Biochemicals & Industries Limited(KREBSBIO)](https://cdn.zonebourse.com/static/address/34067630.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.76% | 43.77B | |
+27.98% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.14% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- KREBSBIO Stock
- KREBSBIO Stock
- Company Krebs Biochemicals & Industries Limited